Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors
Amwell (NYSE: AMWL), a leader in hybrid care enablement, announced the appointment of Ricky Goldwasser to its Board of Directors, effective June 13, 2024. Goldwasser, with a strong financial background and a successful career in healthcare investment and research, is expected to guide Amwell towards profitability and efficient cash flow. She replaces Deval Patrick, a long-time board member who played a important role in Amwell’s IPO and telehealth acceptance. CEO Ido Schoenberg highlighted Goldwasser's potential to help Amwell achieve its goals in the evolving healthcare landscape.
- Ricky Goldwasser's appointment brings a deep financial expertise to Amwell's Board of Directors.
- Goldwasser has a proven track record in healthcare services and technology, having worked at Morgan Stanley and UBS.
- Her experience includes leading successful IPOs, including Amwell's own public offering.
- Goldwasser has been recognized as a top-ranked research analyst by Institutional Investor magazine for 18 years.
- CEO Ido Schoenberg emphasized her ability to guide Amwell towards profitability and optimized cash flow.
- Goldwasser's appointment aligns with Amwell's mission to enhance hybrid care delivery in a digitally transforming healthcare industry.
- The departure of Deval Patrick, a key figure in Amwell's telehealth acceptance and IPO process, might create a gap in continuity.
- The PR does not provide specific financial projections or immediate strategies introduced by Goldwasser.
- There is no mention of immediate changes or potential impacts on current shareholder value.
Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13.
“Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell’s path to profitability. Ricky’s strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growth, while remaining committed to enabling our clients to achieve their goals. We are pleased to welcome Ricky to the team,” said Ido Schoenberg, M.D., CEO and chairman, Amwell.
Ms. Goldwasser has spent her career advising institutional investors and public and private companies across the healthcare services continuum. She spent 15 years at Morgan Stanley where she was a managing director, head of U.S. Healthcare Services & Technology Research and most recently Investment Banking groups, and was co-head of U.S. Healthcare Research at UBS. Throughout her career, she has led many successful initial public offerings, including Amwell’s, and has been recognized by Institutional Investor magazine as a top-ranked research analyst for 18 years.
"I am excited to join Amwell's board at such an important time for the company," said Ms. Goldwasser. "Given the pressures facing healthcare today and the need to address these challenges with digital transformation, I look forward to contributing my experience and insights to support Amwell’s mission of connecting and empowering providers, insurers, and innovators to deliver more accessible, affordable, high-quality care."
Ms. Goldwasser will take the place of departing board member Deval Patrick, who has served on the Amwell board since 2015.
“As a long-time board member, Governor Patrick played a pivotal role in Amwell’s efforts to drive acceptance for telehealth globally, through the company’s IPO in 2020, and to today’s mission to enable the delivery of hybrid care for our clients,” said Schoenberg. “I want to thank Governor Patrick for his valuable contributions and strong leadership throughout his tenure on the Board.”
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.
©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
FAQ
Who was recently appointed to Amwell's Board of Directors?
What is Ricky Goldwasser's background?
How does Ricky Goldwasser's appointment impact Amwell's goals?
Who did Ricky Goldwasser replace on Amwell's Board of Directors?
What significant contributions did Deval Patrick make to Amwell?
